
#pharmaceutical R&D
3 articles


Corporate Finance
NVIDIA's BioNeMo Bets Signal a Tectonic Shift in Pharma R&D Capital Allocation
ViaNews Editorial Team (Finance)•

Pharma & Biotech
GSK Bets Big on Ultra-Long-Acting Biologics With 2027 Depemokimab Launch Target
ViaNews Editorial Team (Finance)•
